May 3, 2024 | Cancer Center News
The Center for Environment, PFAS, and Cancer Toxicology (CEPaCT) held a meeting on April 25 at the Beckman Institute to discuss recent project and administrative updates. CEPaCT was founded by Cancer Center at Illinois (CCIL) member Joseph Irudayaraj and focuses on...
Apr 25, 2024 | Cancer Center News
The CCIL was featured on WCIA during Testicular Cancer Awareness Month. CCIL member Michael Spinella shared the results of his lab’s testicular cancer research, including the development of epigenetic drugs to help patients who don’t respond to...
Apr 24, 2024 | Cancer Center News
A new paper published by a team that includes several Cancer Center at Illinois (CCIL) researchers demonstrates a link between per- and polyfluoroalkyl substances (PFAS) exposure and growth of testicular germ cell tumors. PFAS chemicals, sometimes called forever...
Apr 24, 2024 | Cancer Center News
Testicular cancer is a rare form of one of the world’s most devastating diseases. Most cases respond well to conventional treatments, but a team affiliated with the Cancer Center at Illinois (CCIL) has spent years working on ways to help patients who don’t have that...
May 26, 2021 | Cancer Center News
From left to right: Ratnakar Singh, Michael Spinella, and Zeeshan Fazal Urbana, Ill. – Cancer Center at Illinois scientist, Michael Spinella, has linked the epigenetic changes in testicular germ cell tumors to their cause and cure, opening new avenues of treatment for...
